BridgeMD
New treatment option for Alcohol Use Disorder
Official title Nutritional Intervention to Reduce Alcohol Consumption
ClinicalTrials.gov ID: NCT06787235
What this study is testing
- What it's testing
- To test whether the implementation of a modified ketogenic diet (KD) is efficient in reducing outcome measures in relation to alcohol consumption in patients with alcohol use disorder (AUD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age ≥ 18
- AUD diagnosis according to Diagnostic and Statistical Manual (DSM)-5
- BMI \> 22 (because of potential modified KD-side effect of weight loss)
- Able to give informed consent as documented by signature
- Last alcohol drink intake within 72 hours before treatment initiation
You likely can't join if
- Pregnant or lactating women,
- Inability or contraindications to undergo the investigated intervention (BMI\<18)
- Clinically significant concomitant diseases impairing reasonable decision making (e.g. psychosis, dementia)
- Inability to follow the procedures of the study, e.g. due to language problems, Previous enrolment in a clinical trial
- Patients undergoing opioid maintenance treatment
- Patients taking medications for drinking relapse prevention
See the full eligibility criteria
- Age ≥ 18
- AUD diagnosis according to Diagnostic and Statistical Manual (DSM)-5
- BMI \> 22 (because of potential modified KD-side effect of weight loss)
- Able to give informed consent as documented by signature
- Last alcohol drink intake within 72 hours before treatment initiation
- Pregnant or lactating women,
- Inability or contraindications to undergo the investigated intervention (BMI\<18)
- Clinically significant concomitant diseases impairing reasonable decision making (e.g. psychosis, dementia)
- Inability to follow the procedures of the study, e.g. due to language problems, Previous enrolment in a clinical trial
- Patients undergoing opioid maintenance treatment
- Patients taking medications for drinking relapse prevention
- Patients with a blood hemoglobin A1C (HbA1C) \> 7%
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.